Venturi Wealth Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,200
Closed -$237K 639
2026
Q1
$237K Buy
17,200
+2,500
+17% +$37.7K 0.01% 533
2025
Q4
$265K Hold
14,700
0.01% 484
2025
Q3
$272K Buy
14,700
+700
+5% +$11K 0.01% 462
2025
Q2
$224K Buy
+14,000
New +$250K 0.01% 498
2025
Q1
Sell
-9,000
Closed -$198K 803
2024
Q4
$198K Hold
9,000
0.01% 548
2024
Q3
$152K Buy
9,000
+2,000
+29% +$29.7K 0.01% 478
2024
Q2
$83.7K Buy
+7,000
New +$78.2K 0.01% 539

Other funds holding CLBT

Venturi Wealth Management's CLBT Position: Q2 2026 in Review

Venturi Wealth Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 17,200 shares — an estimated $237K sold.

Venturi Wealth Management first reported a position in CLBT in Q2 2024 and held it in 7 quarters. The position peaked at $272K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Venturi Wealth Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Venturi Wealth Management sold 17,200 Cellebrite shares in Q2 2026, an estimated $237K.
  • Venturi Wealth Management first reported a position in Cellebrite in Q2 2024 and held it in 7 quarters.
  • Venturi Wealth Management's Cellebrite position peaked at $272K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.